Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$105.43−1.68 (-1.57%)
Close on Nov 17, 2026Market cap $60.77BP/E 60.6Yield –
Edwards Lifesciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Edwards Lifesciences's market cap was $61.01B on Nov 11, 2026, against $50.33B a year earlier. Over the last 5 years it ranged from $37.98B to $80.87B, with a median of $49.50B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $61.01B | +23.2% |
| 2025 | Dec 31, 2025 | $49.50B | +13.4% |
| 2024 | Dec 31, 2024 | $43.66B | -5.6% |
| 2023 | Dec 29, 2023 | $46.25B | +0.1% |
| 2022 | Dec 30, 2022 | $46.21B | -42.9% |
| 2021 | Dec 31, 2021 | $80.87B | +42.3% |
| 2020 | Dec 31, 2020 | $56.83B | +16.8% |
| 2019 | Dec 31, 2019 | $48.64B | +51.9% |
| 2018 | Dec 31, 2018 | $32.03B | +34.3% |
| 2017 | Dec 29, 2017 | $23.85B | +19.1% |
| 2016 | Dec 30, 2016 | $20.02B | +17.7% |
| 2015 | Dec 31, 2015 | $17.01B | +24.9% |
| 2014 | Dec 31, 2014 | $13.62B | +89.3% |
| 2013 | Dec 31, 2013 | $7.19B | -31.2% |
| 2012 | Dec 31, 2012 | $10.46B | +29.5% |
| 2011 | Dec 30, 2011 | $8.07B | -12.5% |
| 2010 | Dec 31, 2010 | $9.22B | +78.2% |
| 2009 | Dec 31, 2009 | $5.18B | – |
See a number that looks wrong?